(S)-22-(tert-Butoxycarbonyl)-45,45-dimethyl-10,19,24,43-tetraoxo-3,6,12,15,44-pentaoxa-9,18,23-triazahexatetracontanoic acid (CAS No: 1188328-37-1) is a key pharmaceutical intermediate used in the synthesis of APIs Semaglutide. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: Semaglutide impurity 84, tBuO-Ara-Glu(AEEA-AEEA-OH)-OtBu
CAS No: 1188328-37-1
PubChem CID: 86644529
Mol Formula: C45H83N3O13
Mol Weight: 874.2 g/mol
Used in API: Semaglutide
IUPAC Name: 2-[2-[2-[[2-[2-[2-[[(4S)-5-[(2-methylpropan-2-yl)oxy]-4-[[20-[(2-methylpropan-2-yl)oxy]-20-oxoicosanoyl]amino]-5-oxopentanoyl]amino]ethoxy]ethoxy]ac -Show More
API Intermediate Description: This compound is a peptide side chain used in the synthesis of GIP/GLP-1 dual agonist drugs, such as tirzepatide and semaglutide. It is a complex, protected peptide fragment, meaning it contains protecting groups like tert-butyloxycarbonyl (Boc) to prevent unwanted reactions during the synthesis of a larger therapeutic peptide.
